Literature DB >> 19705549

A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia.

Rahul Agrawal1, Ethika Tyagi, Rakesh Shukla, Chandishwar Nath.   

Abstract

In the present study, role of brain insulin receptors (IRs) in memory functions and its correlation with acetylcholinesterase (AChE) activity and oxidative stress in different brain regions were investigated in intracerebroventricular (ICV) streptozotocin (STZ) induced dementia model. Rats were treated with STZ (3 mg/kg, ICV) on day 1 and 3. Donepezil (5 mg/kg po) and melatonin (20 mg/kg ip) were administered in pre- and post-treatment schedules. Morris water maze test was done on day 14 and animals were sacrificed on day 21 from 1st STZ injection. Memory deficit was found in STZ group as indicated by no significant decrease in latency time antagonized by donepezil and melatonin. IR protein level was found significantly increased in trained group as compared to control, whereas STZ decreased IR level significantly as compared to trained rats in hippocampus which indicates that IR is associated with memory functions. STZ induced decrease in IR was reversed by melatonin but not by donepezil. Melatonin per se did not show any significant change in IR level as compared to control. AChE activity (DS and SS fraction) was found to be increased in hippocampus in STZ group as compared to trained which was inhibited by donepezil and melatonin. Increase in MDA level and decrease in GSH level were obtained in STZ group indicating oxidative stress, which was attenuated by donepezil and melatonin. Effectiveness of antioxidant, melatonin but not of anti-cholinesterase, donepezil against STZ induced changes in IR indicates that IR is more affected with oxidative stress than cholinergic changes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705549     DOI: 10.1016/j.neuropharm.2009.01.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  42 in total

Review 1.  Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.

Authors:  Pradip K Kamat; Anuradha Kalani; Shivika Rai; Santosh Kumar Tota; Ashok Kumar; Abdullah S Ahmad
Journal:  Mol Neurobiol       Date:  2015-08-23       Impact factor: 5.590

2.  Treadmill Exercise Exerts Neuroprotection and Regulates Microglial Polarization and Oxidative Stress in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease.

Authors:  Yujiao Lu; Yan Dong; Donovan Tucker; Ruimin Wang; Mohammad Ejaz Ahmed; Darrell Brann; Quanguang Zhang
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 3.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

4.  Long Acting Ionically Paired Embonate Based Nanocrystals of Donepezil for the Treatment of Alzheimer's Disease: a Proof of Concept Study.

Authors:  Naresh Mittapelly; Maharshi Thalla; Gitu Pandey; Venkatesh Teja Banala; Shweta Sharma; Abhishek Arya; Sandeep Mishra; Kalyan Mitra; Shubha Shukla; Prabhat Ranjan Mishra
Journal:  Pharm Res       Date:  2017-08-14       Impact factor: 4.200

5.  Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats.

Authors:  N Rajasekar; Chandishwar Nath; Kashif Hanif; Rakesh Shukla
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

6.  Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.

Authors:  E Sofic; M Salkovic-Petrisic; I Tahirovic; A Sapcanin; S Mandel; M Youdim; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2014-09-25       Impact factor: 3.575

7.  'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition.

Authors:  Rahul Agrawal; Fernando Gomez-Pinilla
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

8.  Decrease in Adult Neurogenesis and Neuroinflammation Are Involved in Spatial Memory Impairment in the Streptozotocin-Induced Model of Sporadic Alzheimer's Disease in Rats.

Authors:  Taysa Bervian Bassani; Jéssica M Bonato; Meira M F Machado; Valentín Cóppola-Segovia; Eric L R Moura; Silvio M Zanata; Rúbia M M W Oliveira; Maria A B F Vital
Journal:  Mol Neurobiol       Date:  2017-06-16       Impact factor: 5.590

9.  Embelin Attenuates Intracerebroventricular Streptozotocin-Induced Behavioral, Biochemical, and Neurochemical Abnormalities in Rats.

Authors:  Rimpi Arora; Rahul Deshmukh
Journal:  Mol Neurobiol       Date:  2016-10-15       Impact factor: 5.590

10.  Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.

Authors:  Mirna Ezzat Sorial; Nesrine Salah El Dine El Sayed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.